Acceleron Pharma Inc Price/Book
Cos'è Price/Book di Acceleron Pharma Inc?
Price/Book di Acceleron Pharma Inc è 12.78
Qual è la definizione di Price/Book?
Il rapporto Price to book rappresenta il rapporto tra il valore delle azioni di una società e il valore contabile per azione.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book di aziende nel Health Care settore su NASDAQ rispetto a Acceleron Pharma Inc
Cosa fa Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Aziende con price/book simili a Acceleron Pharma Inc
- Sartorius Stedim Biotech SA ha Price/Book di 12.73
- United Labels AG ha Price/Book di 12.76
- Asahi India Glass ha Price/Book di 12.77
- Public Joint Stock Mining and Metallurgical Norilsk Nickel ha Price/Book di 12.77
- Wise Ally International ha Price/Book di 12.78
- Fortinet ha Price/Book di 12.78
- Acceleron Pharma Inc ha Price/Book di 12.78
- Xero ha Price/Book di 12.79
- V2 Retail ha Price/Book di 12.80
- AVZ Minerals ha Price/Book di 12.80
- Vista Gold ha Price/Book di 12.82
- Travelzoo ha Price/Book di 12.83
- Burlington Stores Inc ha Price/Book di 12.83